Described herein are devices and methods for pumping fluids. The devices may be implanted within a patient or located external to the body of the patient. When employed externally, the devices may be used to deliver various drugs or support hemodialysis, in addition to pumping blood and maintaining blood circulation. The implantable devices may be used in patients in need of circulatory assistance or a replacement heart. Both the implantable and external pump devices may linearly reciprocate a shuttle within a housing to simultaneously move blood into and out of the housing, and rotate the shuttle to selectively direct the movement of fluid into and out of a plurality of ports in the housing.

A positive displacement pump that triggers with the beating of a mammalian heart, through the monitoring of an ECG signal is disclosed. A programmable delay from the detection of the forthcoming contraction of the heart enables the pump to syncopate the ejection of the fluid with the events occurring in the cardiovascular system. This delayed ejection could be used to overlay the ejected fluid from the pump with a pressure wave in the artery of systemic circulation through a catheter connection between the pump and a physiological model (e.g., cow, dog, human). The outcome of this use could be to raise the pulse pressure in the system to take advantage of physiological pathways that respond to this transient change in blood pressure. The novelty of this system stems from the adaptable control architecture designed to augment the pulsatile characteristics of the cardiovascular system. This inventive concept could be expanded to encompass the augmentation (dampen or enhance) of pulsatile characteristics in any oscillating flow system.

A positive displacement pump that triggers with the beating of a mammalian heart, through the monitoring of an ECG signal is disclosed. A programmable delay from the detection of the forthcoming contraction of the heart enables the pump to syncopate the ejection of the fluid with the events occurring in the cardiovascular system. This delayed ejection could be used to overlay the ejected fluid from the pump with a pressure wave in the artery of systemic circulation through a catheter connection between the pump and a physiological model (e.g., cow, dog, human). The outcome of this use could be to raise the pulse pressure in the system to take advantage of physiological pathways that respond to this transient change in blood pressure. The novelty of this system stems from the adaptable control architecture designed to augment the pulsatile characteristics of the cardiovascular system. This inventive concept could be expanded to encompass the augmentation (dampen or enhance) of pulsatile characteristics in any oscillating flow system.

A pump having at least a fluid pump chamber (11) and a first driver chamber (12) separated from the fluid pump chamber (11) by an elastic wall (13, 13-1, 13-2) is described with the first driver chamber (12) expanding after a chemical reaction between fuel and oxidant and driving through deformation of the elastic wall fluid out of the fluid pump chamber (11), with the main parts of the pump being made of an elastic material to be used for example as a body implant.

A positive displacement pump that triggers with the beating of a mammalian heart, through the monitoring of an ECG signal is disclosed. A programmable delay from the detection of the forthcoming contraction of the heart enables the pump to syncopate the ejection of the fluid with the events occurring in the cardiovascular system. This delayed ejection could be used to overlay the ejected fluid from the pump with a pressure wave in the artery of systemic circulation through a catheter connection between the pump and a physiological model (e.g., cow, dog, human). The outcome of this use could be to raise the pulse pressure in the system to take advantage of physiological pathways that respond to this transient change in blood pressure. The novelty of this system stems from the adaptable control architecture designed to augment the pulsatile characteristics of the cardiovascular system. This inventive concept could be expanded to encompass the augmentation (dampen or enhance) of pulsatile characteristics in any oscillating flow system.

An autologous left ventricular assist device (ALVAD) is implanted into a skeletal muscle of a patient, such as being nested in the Latissimus Dorsi muscle. This implantation may be referred to as a training or prefabrication step and may last for 3 to 6 months or even longer. The ALVAD may include a plurality of ribs distributed in a spiral configuration as structural support and may include a plurality of electrodes operative to cause repeated contractions of the latissimus dorsi muscle. Once trained, the autologous LVADnow integrated into the conditioned musclemay be repositioned, reshaped and, specifically, moved into proximity with the patient's own heart and operatively coupled in fluid communication therewith for repeatedly contracting so as to pump oxygenated blood to and through the aorta and to the patient's organs and tissues.

An autologous left ventricular assist device (ALVAD) is implanted into a skeletal muscle of a patient, such as being nested in the Latissimus Dorsi muscle. This implantation may be referred to as a training or prefabrication step and may last for 3 to 6 months or even longer. The ALVAD may include a plurality of ribs distributed in a spiral configuration as structural support and may include a plurality of electrodes operative to cause repeated contractions of the latissimus dorsi muscle. Once trained, the autologous LVADnow integrated into the conditioned musclemay be repositioned, reshaped and, specifically, moved into proximity with the patient's own heart and operatively coupled in fluid communication therewith for repeatedly contracting so as to pump oxygenated blood to and through the aorta and to the patient's organs and tissues.

Systems and methods are provided herein for improving connections between a heart pump, such a left ventricular assist device (LVAD), and the heart and/or tubing such as a graft tube. An apical connector including a cylindrical housing and a ring support connected to the housing is described. The apical connector may include a sewing ring to be connected to the patient's heart and a spring positioned within the cylindrical housing to engage a portion of the pump and secure the apical connector to the pump. Alternatively, an apical connector may include an upper and lower housing with locks positioned in channels between the housings and may include a handle and a ring to cause the locks to engage a portion of the pump. A quick connect assembly is also described for efficiently connecting a graft tube to an outlet of a heart pump using a flange with through-holes and protrusions.

Systems and methods are provided herein for improving connections between a heart pump, such a left ventricular assist device (LVAD), and the heart and/or tubing such as a graft tube. An apical connector including a cylindrical housing and a ring support connected to the housing is described. The apical connector may include a sewing ring to be connected to the patient's heart and a spring positioned within the cylindrical housing to engage a portion of the pump and secure the apical connector to the pump. Alternatively, an apical connector may include an upper and lower housing with locks positioned in channels between the housings and may include a handle and a ring to cause the locks to engage a portion of the pump. A quick connect assembly is also described for efficiently connecting a graft tube to an outlet of a heart pump using a flange with through-holes and protrusions.

Systems and methods are provided herein for improving connections between a heart pump, such a left ventricular assist device (LVAD), and the heart and/or tubing such as a graft tube. An apical connector including a cylindrical housing and a ring support connected to the housing is described. The apical connector may include a sewing ring to be connected to the patient's heart and a spring positioned within the cylindrical housing to engage a portion of the pump and secure the apical connector to the pump. Alternatively, an apical connector may include an upper and lower housing with locks positioned in channels between the housings and may include a handle and a ring to cause the locks to engage a portion of the pump. A quick connect assembly is also described for efficiently connecting a graft tube to an outlet of a heart pump using a flange with through-holes and protrusions.